1. Home
  2. AIMD vs IRIX Comparison

AIMD vs IRIX Comparison

Compare AIMD & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ainos Inc.

AIMD

Ainos Inc.

SELL

Current Price

$1.24

Market Cap

10.6M

Sector

Health Care

ML Signal

SELL

Logo IRIDEX Corporation

IRIX

IRIDEX Corporation

N/A

Current Price

$0.44

Market Cap

12.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AIMD
IRIX
Founded
1984
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.6M
12.6M
IPO Year
2008
1996

Fundamental Metrics

Financial Performance
Metric
AIMD
IRIX
Price
$1.24
$0.44
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 4.0M
47.7K
Earning Date
11-16-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 51.85
EPS
N/A
★ N/A
Revenue
$124,157.00
★ $41,593,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 498.95
N/A
52 Week Low
$0.43
$0.45
52 Week High
$3.88
$1.65

Technical Indicators

Market Signals
Indicator
AIMD
IRIX
Relative Strength Index (RSI) 60.79 26.17
Support Level $0.50 N/A
Resistance Level $1.75 $1.16
Average True Range (ATR) 0.30 0.05
MACD 0.08 -0.03
Stochastic Oscillator 51.47 10.02

Price Performance

Historical Comparison
AIMD
IRIX

About AIMD Ainos Inc.

Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format.

About IRIX IRIDEX Corporation

IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

Share on Social Networks: